rs141330687

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_030962.4(SBF2):​c.2323G>A​(p.Gly775Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00366 in 1,614,170 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0027 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0038 ( 17 hom. )

Consequence

SBF2
NM_030962.4 missense

Scores

10
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts P:1B:15

Conservation

PhyloP100: 3.29
Variant links:
Genes affected
SBF2 (HGNC:2135): (SET binding factor 2) This gene encodes a pseudophosphatase and member of the myotubularin-related protein family. This gene maps within the CMT4B2 candidate region of chromosome 11p15 and mutations in this gene have been associated with Charcot-Marie-Tooth Disease, type 4B2. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010010332).
BP6
Variant 11-9856498-C-T is Benign according to our data. Variant chr11-9856498-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 194989.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-9856498-C-T is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAdExome4 at 17 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SBF2NM_030962.4 linkuse as main transcriptc.2323G>A p.Gly775Ser missense_variant 19/40 ENST00000256190.13 NP_112224.1 Q86WG5-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SBF2ENST00000256190.13 linkuse as main transcriptc.2323G>A p.Gly775Ser missense_variant 19/401 NM_030962.4 ENSP00000256190.8 Q86WG5-1

Frequencies

GnomAD3 genomes
AF:
0.00273
AC:
416
AN:
152196
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000700
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00222
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00352
Gnomad FIN
AF:
0.000942
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00470
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.00320
AC:
805
AN:
251432
Hom.:
6
AF XY:
0.00326
AC XY:
443
AN XY:
135882
show subpopulations
Gnomad AFR exome
AF:
0.000800
Gnomad AMR exome
AF:
0.00393
Gnomad ASJ exome
AF:
0.000198
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00297
Gnomad FIN exome
AF:
0.000970
Gnomad NFE exome
AF:
0.00448
Gnomad OTH exome
AF:
0.00538
GnomAD4 exome
AF:
0.00376
AC:
5491
AN:
1461856
Hom.:
17
Cov.:
33
AF XY:
0.00378
AC XY:
2749
AN XY:
727228
show subpopulations
Gnomad4 AFR exome
AF:
0.000448
Gnomad4 AMR exome
AF:
0.00400
Gnomad4 ASJ exome
AF:
0.000153
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00311
Gnomad4 FIN exome
AF:
0.00142
Gnomad4 NFE exome
AF:
0.00427
Gnomad4 OTH exome
AF:
0.00275
GnomAD4 genome
AF:
0.00273
AC:
416
AN:
152314
Hom.:
1
Cov.:
32
AF XY:
0.00256
AC XY:
191
AN XY:
74490
show subpopulations
Gnomad4 AFR
AF:
0.000698
Gnomad4 AMR
AF:
0.00222
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00352
Gnomad4 FIN
AF:
0.000942
Gnomad4 NFE
AF:
0.00470
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.00401
Hom.:
2
Bravo
AF:
0.00258
TwinsUK
AF:
0.00378
AC:
14
ALSPAC
AF:
0.00441
AC:
17
ESP6500AA
AF:
0.00114
AC:
5
ESP6500EA
AF:
0.00419
AC:
36
ExAC
AF:
0.00322
AC:
391
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00540
EpiControl
AF:
0.00439

ClinVar

Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:6
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsAug 12, 2019- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenNov 01, 2023SBF2: BS2 -
Likely benign, criteria provided, single submitterclinical testingGeneDxDec 04, 2020- -
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsOct 10, 2016- -
not specified Benign:3
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Nov 09, 2014- -
Likely benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoJul 08, 2019- -
Likely benign, criteria provided, single submitterclinical testingMendelicsMay 04, 2022- -
Charcot-Marie-Tooth disease type 4B2 Benign:2
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 30, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesOct 25, 2022- -
Tip-toe gait Pathogenic:1
Likely pathogenic, flagged submissionclinical testingPractice for Gait Abnormalities, David Pomarino, Competency Network Toe Walking c/o Practice PomarinoMay 20, 2019We conducted a clinical examination of patients about toe walking. The SBF2:c.2323G>A was detected in 5 patients. We also examined a control group of children without toe walking (100 children). In this group this variant could not be identified. Hereditary motor sensory neuropathy (HMSN), also known as Charcot-Marie-Tooth Disease (CMT), is the most commonly inherited peripheral polyneuropathy. It constitutes a group of inherited, progressive, motor and sensory peripheral nerve disorders with properties of demyelination, axonal degeneration, or both. It is classified by clinical characteristics, modes of inheritance, electrophysiologic features, metabolic defects, and specific gene markers. Our patients all walk on tiptoe, so they show similar symptoms. When we genetically test them with our toe walking panel, we find that around 90 per cent of them have a genetic variant that explains their toe walking. These can be assigned, for example, to the area of myopathies (such as variants of the COL6A3 gene), the area of hereditary neuropathies (such as variants of the KMT2C gene) or the area of metabolic diseases (such as variants of the PYGM gene). In a smaller group of patients with almost identical symptoms, no abnormality is found in the genes of our panel, but spastic paraplegia can be detected. In another small group of our toe walkers, no abnormalities can be detected in the genes analysed in our toe walking panel, nor do they suffer from spastic paraplegia, as is also the case with healthy children. In contrast to these, however, they show a tiptoe gait. These patients suffer from infantile cerebral palsy, in which toe walking can also be observed. -
Charcot-Marie-Tooth disease Benign:1
Likely benign, criteria provided, single submitterclinical testingMolecular Genetics Laboratory, London Health Sciences Centre-- -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsAug 27, 2019This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
SBF2-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMar 26, 2019This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Charcot-Marie-Tooth disease type 4 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.16
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.23
T
Eigen
Uncertain
0.27
Eigen_PC
Uncertain
0.35
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.97
D
M_CAP
Uncertain
0.095
D
MetaRNN
Benign
0.010
T
MetaSVM
Uncertain
-0.15
T
MutationAssessor
Benign
1.5
L
PrimateAI
Uncertain
0.67
T
PROVEAN
Uncertain
-2.9
D
REVEL
Uncertain
0.36
Sift
Benign
0.36
T
Sift4G
Benign
0.36
T
Polyphen
0.76
P
Vest4
0.47
MVP
0.90
MPC
0.19
ClinPred
0.020
T
GERP RS
5.3
Varity_R
0.20
gMVP
0.35

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs141330687; hg19: chr11-9878045; COSMIC: COSV56304153; API